In conversation with Fierce Pharma, Anthony Billinger, senior director of Compass Strategy at Veeva Systems, sheds light on the rapidly evolving world of commercial data in life sciences—and why the ...

Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) ('Tiziana”), a biotechnology company developing its lead candidate, intranasal foralumab, a fully human, anti-CD3 monoclonal antibody, announces positive new ...

Drug development and commercialization leads to tremendous advances in medicine and improvements to everyday life, but it often comes at a cost. Delayed clinical trials, regulatory approvals, and ...

Legend has it that physicist Ernest Rutherford once dismissed all sciences other than physics as mere “stamp collecting.” (Whether he actually said it is a matter of some debate.) But we now live in ...

In life sciences research and development (R&D), to truly enhance fragmented data, it must be both accessible and relevant. LabVantage BioTech360 serves as the platform that guarantees valuable ...

Buoyed by the rapid development of COVID-19 vaccines, the life sciences industry is on track for a succession of upheavals already transforming patient care, business models, and market dynamics. In ...

Biotechnology and precision medicine company Caris Life Sciences announced it raised $168 million in growth capital funding. Caris Life Sciences has now raised $1.86 billion in capital since 2018.

Dr. Thomas J. Lynch Jr. is a world-renowned scientist, highly respected oncologist and successful leader of National Cancer Institute-Designated Comprehensive Cancer Centers . As president and ...